Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldara as Adjunct to Laser for Port Wine Stains
NCT00979550Phase 2Terminated
- Start
- Oct 2008
- Primary completion
- Aug 2013
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of imiquimod in port-wine stain. Started Oct 2008; status: terminated.
02
Drugs
imiquimod
03
Conditions
port-wine stain
Beyond the preview
Go deeper on NCT00979550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979550.